| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhuang,Ming-Xi | Chairman | 2.25% | |
| Qiu,Chun-Fen | Director | 0.98% | |
| Chen,Bai-Ru | Director | 0.84% | |
| Luo,Ling | Director | 5.25% | |
| Kang,Xi-Dong | Director | 1.78% | |
| He,Nuan-Xuan | Director | 0.05% | |
| He,Li-Xing | Director | 1.53% | |
| Chen,Zhen-Jiang | Independent Director | 0.05% | |
| Yu,Shi-Di | Independent Director | 0.00% | |
| Luo,Rong-Zhen | Independent Director | 0.00% |
Change Company Name to GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.
2023/11/07
Change Company Name to GUOXI STEM CELL APPLICATION TECHNOLOGY CO., LTD. (FORMER NAME: GUOXI STEM CELL BIOTECHNOLOGY CO., LTD.)
2022/07/18
Change Capital to 1,500,000,000
2019/10/29
Change Person in Charge to Zhuang,Ming-Xi
2014/01/08
Change Person in Charge to Zhu,Geng-Ting
2013/04/09
Change Person in Charge to Liu,Li-Guang-Jian-Kang-Shi-Ye-You-Xian-Gong-Si
2012/06/29
Change Person in Charge to Zheng,Han-Zhong
2012/05/14
Change Capital to 1,000,400,000
2012/02/02
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 79,607 | 141,176 | 180,667 |
| Operating cost | 25,002 | 44,402 | 25,861 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 54,605 | 96,774 | 154,806 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 54,605 | 96,774 | 154,806 |
| Operating expenses | 99,267 | 190,729 | 270,096 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -44,662 | -93,955 | -115,290 |
| Non-operating income and expenses | -3,450 | 6,805 | 4,354 |
| Net profit (loss) before tax | -48,112 | -87,150 | -110,936 |
| Income tax expense (benefits) | 13 | 939 | 677 |
| Net profit (loss) of ongoing business for the current period | -48,125 | -88,089 | -111,613 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -48,125 | -88,089 | -111,613 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -48,125 | -88,089 | -111,613 |
| Net profit (loss) attributable to owners of parent company | -48,125 | -88,089 | -112,107 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | 0 |
| Net profit (loss) attributable to non-controlling interests | - | 0 | 494 |
| Comprehensive profit (loss) attributable to owners of parent company | -48,125 | -88,089 | -112,107 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | 0 |
| Comprehensive profit (loss) attributable to non-controlling interests | - | 0 | 494 |
| Basic earnings per share (yuan) | 0 | 0 | -1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -28,914 | -4,874 | -64,193 |
| Net cash inflows (outflows) from investing activities | -13,513 | -33,074 | -6,729 |
| Net cash inflow (outflow) from financing activities | -30,320 | 239,948 | 93,271 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -72,747 | 202,000 | 22,349 |
| Beginning balance of cash and cash equivalents | 342,965 | 140,965 | 118,616 |
| Ending balance of cash and cash equivalents | 270,218 | 342,965 | 140,965 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 363,746 | 424,361 | 200,779 |
| Non-current asset | 780,878 | 801,355 | 844,112 |
| Total asset | 1,144,624 | 1,225,716 | 1,044,891 |
| Current liability | 103,373 | 115,481 | 106,665 |
| Non-current liability | 345,147 | 366,006 | 427,908 |
| Total liability | 448,520 | 481,487 | 534,573 |
| share capital | 959,493 | 959,493 | 878,993 |
| Equity - secruity token | - | - | - |
| capital reserve | 0 | 241,500 | 95,134 |
| retained earning | -263,389 | -456,764 | -463,809 |
| Other equity | - | - | - |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 696,104 | 744,229 | 510,318 |
| Equity attributable to former owner of business combination under common control | - | - | 0 |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | 0 | 0 |
| Total Equity | 696,104 | 744,229 | 510,318 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 7 | 7 | 5 |
